reglab/housing_qa huggingface dataset:
HI Rev Stat § 328-120 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328. Food, Drugs, and Cosmetics|328-120 Recordkeeping.

  §328-120 Recordkeeping. (a) Wholesale distributors shall establish and maintain inventories and records of all transactions regarding the receipt and distribution or other disposition of prescription drugs. These records shall include the following information:  (1) The source of the drugs, including the name and principal address of the seller or transferor, and the address of the location from which the drugs were shipped;  (2) The identity and quantity of the drugs received and distributed or disposed of; and  (3) The dates of receipt and distribution or other disposition of the drugs.  (b) Inventories and records shall be made available for inspection and photocopying by the department or any authorized federal, state, or local law enforcement officials for a period of five years following disposition of the drugs.  (c) Records described in this section that are kept at the inspection site or that can be retrieved immediately by computer or other electronic means shall be readily available for authorized inspection during the retention period. Records kept at a central location apart from the inspection site and not electronically retrievable shall be made available for inspection within two working days of a request by the department or any authorized official of a federal, state, or local law enforcement agency. [L 1992, c 196, pt of §2]
HI Rev Stat § 328-121 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328. Food, Drugs, and Cosmetics|328-121 Written policies and procedures.

  §328-121 Written policies and procedures. Wholesale distributors shall establish, maintain, and follow written policies and procedures for the receipt, security, storage, inventory, and distribution of prescription drugs, including policies and procedures for identifying, recording, and reporting losses or thefts and for correcting all errors and inaccuracies in inventories. Wholesale distributors shall include in their written policies and procedures the following:  (1) A procedure whereby the oldest approved stock of a prescription drug is distributed first. The procedure may permit deviation from this requirement if the deviation is temporary and appropriate.  (2) A procedure for handling recalls and withdrawals of prescription drugs. The procedure shall be adequate to deal with recalls and withdrawals caused by:  (A) Any action initiated at the request of the department, the Food and Drug Administration, or any other federal, state, or local law enforcement or other government agency;  (B) Any voluntary action by the manufacturer to remove defective or potentially defective drugs from the market; or  (C) Any action undertaken to promote public health and safety by replacing existing merchandise with an improved product or new package design.  (3) A procedure to ensure that the distributor prepares for, protects against, and handles properly any crisis that affects security or operation of any facility in the event of strike, fire, flood, or other natural disaster, or in other emergencies.  (4) A procedure to ensure that all outdated prescription drugs are segregated from other drugs and either returned to the manufacturer or destroyed. This procedure shall require written documentation of the disposition of outdated prescription drugs, which documentation shall be maintained for five years after disposition of the outdated drugs. [L 1992, c 196, pt of §2]
HI Rev Stat § 328-122 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328. Food, Drugs, and Cosmetics|328-122 Responsible persons.

  §328-122 Responsible persons. Wholesale distributors shall establish and maintain current lists of officers, directors, managers, and other persons in charge of the wholesale distribution, storage, and handling of prescription drugs, including a description of each person's duties and a summary of each person's qualifications. [L 1992, c 196, pt of §2]
HI Rev Stat § 328-123 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328. Food, Drugs, and Cosmetics|328-123 Salvaging and reprocessing.

  §328-123 Salvaging and reprocessing. Wholesale distributors shall be subject to the provisions of 21 Code of Federal Regulations Parts 207, 210, and 211, regarding salvaging and reprocessing of prescription drugs. [L 1992, c 196, pt of §2]
HI Rev Stat § 328C-1 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328C. Donation of Pharmaceuticals and Health Care Supplies|328C-1 Definitions.

  §328C-1 Definitions. Whenever used in this chapter unless the context otherwise requires:  "Charitable, religious, or nonprofit organization" means any organization which was organized and is operating in the State for charitable or religious purposes or to promote social welfare, which is exempt from income taxation under chapter 235, and which distributes pharmaceuticals and health care supplies at no cost to needy persons.  "Institutional facility" means a:  (1) Hospital;  (2) Convalescent home;  (3) Nursing home;  (4) Extended care facility;  (5) Mental institution;  (6) Rehabilitation center;  (7) Health maintenance organization;  (8) Psychiatric center;  (9) Intellectual disability center;  (10) Penal institution; or  (11) Any other organization whose primary purpose is to provide a physical environment for patients to obtain health care services or at-home care services, except those places where physicians, dentists, veterinarians, osteopaths, podiatrists, or other prescribers who are duly licensed, engage in private practice.  "Needy person" means any natural person who lacks the means to obtain adequate or proper pharmaceuticals or health care supplies, as determined by a practitioner at a Hawaii qualified health center, established under section 346-41.5, to be in need of service.  "Pharmaceuticals and health care supplies" means any medicine (prescription or nonprescription, excluding all controlled substances listed in chapter 329) or health care supplies such as soap, personal sanitary products, baby formula, dietary supplement, health care aids such as thermometers, surgical gloves, or bandages, or any other item which is customarily fit for human consumption or external use, before the expiration date stamped on the product, if any. [L 1997, c 337, pt of §2; am L 2001, c 207, §1; am L 2004, c 190, § §4, 11; L 2011, c 220, §12]
HI Rev Stat § 328C-3 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328C. Donation of Pharmaceuticals and Health Care Supplies|328C-3 Sale of donated pharmaceuticals or health care supplies, prohibited; fines.

  §328C-3 Sale of donated pharmaceuticals or health care supplies, prohibited; fines. (a) No person or organization shall sell, or offer for sale, any pharmaceutical or health care supply donated or distributed under this chapter.  (b) Any violation of this section is punishable by a fine not to exceed $1,000. [L 1997, c 337, pt of §2]
HI Rev Stat § 328C-4 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328C. Donation of Pharmaceuticals and Health Care Supplies|328C-4 Labeling of donated pharmaceuticals or health care supplies.

  §328C-4 Labeling of donated pharmaceuticals or health care supplies. Any charitable, religious, or nonprofit organization which receives and distributes donated pharmaceuticals or health care supplies pursuant to this chapter shall affix a label upon those items stating that the items are donated and are not for resale and stating that they were fit for human consumption or use on the date that they left control of the charitable, religious, or nonprofit organization. [L 1997, c 337, pt of §2]
HI Rev Stat § 328C-5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328C. Donation of Pharmaceuticals and Health Care Supplies|328C-5 Reserving the State's authority to regulate, inspect, or ban the use of donated pharmaceuticals or health care supplies.

  §328C-5 Reserving the State's authority to regulate, inspect, or ban the use of donated pharmaceuticals or health care supplies. Nothing in this chapter is intended to restrict the authority of any state department to regulate, inspect, or ban the use of donated pharmaceuticals or health care supplies for human consumption or use. Pharmaceuticals and health care supplies that are distributed by a charitable, religious, or nonprofit organization, and the activities associated with that distribution, shall comply with the applicable provisions of chapter 328, including part VII, which relates to prescription drug wholesalers. Any provisions to the contrary notwithstanding, all activities conducted by an organization under this chapter involving the distribution of prescription drugs to persons other than a consumer or patient shall be included within the definition of "wholesale distribution" as defined by section 328-112. [L 1997, c 337, pt of §2]
HI Rev Stat § 328C-6, 7 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328C. Donation of Pharmaceuticals and Health Care Supplies|328C-6, 7 REPEALED.

  § §328C-6, 7 REPEALED. L 2004, c 190, §11.
HI Rev Stat § 328D-2 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-2 Product quality.

  §328D-2 Product quality. (a) All bottled water shall be from an approved source and shall not contain any constituent in quantities that may be injurious to health, as established by rules adopted by the department or other government agency or agencies having jurisdiction. All bottled water shall meet standards prescribed by the FDA in title 21 C.F.R. section 165.110.  (b) Except as provided in subsection (a), bottled water, including mineral water, shall not exceed any maximum contaminant level (MCL) established by the EPA under the Safe Drinking Water Act or standards established by the department or other government agency or agencies having jurisdiction for any organic or inorganic chemical. [L 1988, c 304, pt of §1; am L 2021, c 161, §2]
HI Rev Stat § 328D-3 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-3 Manufacturing, operations; requirements.

  §328D-3 Manufacturing, operations; requirements. (a) All bottled water, including mineral water, shall be filtered and processed and packaged in accordance with the FDA good manufacturing practice regulations (GMPs) 21 C.F.R. Parts 110 and 129, and any other rules adopted by the department or government agency or agencies having jurisdiction.  (b) Bottled water production, including transporting, processing, packaging, and storage, shall be conducted under conditions and controls necessary to minimize the potential for microbiological contamination of the finished product. These conditions and controls shall include the following:  (1) Bottled water shall be subject to effective germicidal treatment by ozonation or carbonation at a minimum of three volumes of carbon dioxide or other equivalent disinfection approved by the department or government agency or agencies having jurisdiction; and  (2) Bottled water shall not be transported or stored in bulk tanks or processed or bottled through equipment or lines used for any nonfood product.  (d) Artesian water may be collected with the assistance of external force to enhance the natural underground pressure so long as such measures do not alter the physical properties, composition, and quality of the water.  (e) Natural water shall not be modified by blending with water of another type or by deletion or addition of dissolved solids except as related to disinfection or other treatment to reduce the concentration of any naturally present constituent which exceeds government-sanctioned or approved safety standards or guidelines. It may be collected and transported by pumps, pipes, tunnels, trucks, or similar devices.  (f) Spring water shall be collected only at the spring or through a bore hole that is adjacent to the point of emergence. Spring water collected with the assistance of external force to protect the water shall retain all the physical properties of and be of the same composition and quality as the water that flows naturally to the surface of the earth. [L 1988, c 304, pt of §1; am L 2021, c 161, §3]
HI Rev Stat § 328D-4 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-4 Source water monitoring.

  §328D-4 Source water monitoring. (a) The plant operator shall be responsible for sampling and analysis of all approved sources for the contaminants specified in section 328D-2 to assure that product water derived from approved sources continues to comply with section 328D-2. Such monitoring shall be at least annually, except that analysis for microbiological contaminants shall be weekly if the source is other than a public water system.  (b) Approved sources shall be monitored every four years for contaminants for which the EPA under the Safe Drinking Water Act, the department, or other government agency or agencies having jurisdiction requires source water monitoring.  (c) In lieu of source monitoring required by this section, a plant operator using a public water system as its source may obtain and display a certificate from the public water system demonstrating that the public water system conducts the monitoring required by this section.  (d) Where a bottled water plant operator, water dealer, or regulatory agency knows or has reason to believe that a contaminant not otherwise monitored is present in the source water because of a spill, release of a hazardous substance, or otherwise, and its presence would create a potential health hazard to consumers, the plant operator or water dealer upon receipt of such information shall monitor the source water for the contaminant.  (e) Detection of any contaminant in source monitoring required pursuant to this section shall be followed immediately by a program of periodic monitoring to confirm the presence in the source water of the contaminant. If the listed unregulated contaminant is confirmed to be present in the source water at a concentration that exceeds a published EPA health advisory, or an FDA or department or other government agency action level for drinking water, the plant operator or water dealer shall employ appropriate treatment techniques to remove or to reduce the contaminant in the product water below the concentration and shall employ a program of periodic monitoring for the contaminant in the source water until such time as the contaminant is not detectable in the source water.  (f) The required source water sampling shall be performed by qualified personnel and required analysis shall be performed by an approved laboratory. Records of the required sampling and analyses shall be maintained on file at the plant for not less than two years and shall be available for official review upon request of the department or other government agency or agencies having jurisdiction. [L 1988, c 304, pt of §1]
HI Rev Stat § 328D-5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-5 Finished product monitoring.

  §328D-5 Finished product monitoring. (a) To assure that bottled water complies with section 328D-2, the following product monitoring of representative samples derived from the bottled product shall be performed:  (1) For microbiological contaminants specified in section 328D-2, a representative sample from a batch or segment of a continuous production for each type of bottled water produced by the plant shall be analyzed weekly; and  (2) For chemical, physical, and radiological contaminants specified in section 328D-2, a representative sample from a batch or segment of continuous product run for each type of bottled drinking water produced by the plant shall be analyzed annually.  (b) The required product water sampling shall be performed by qualified personnel and required analysis shall be performed by an approved laboratory.  (c) Records of required sampling and analysis shall be maintained at the plant not less than two years and shall be available for official review upon request of the department or government agency or agencies having jurisdiction. [L 1988, c 304, pt of §1]
HI Rev Stat § 328D-6 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-6 Labeling requirements.

  §328D-6 Labeling requirements. All bottled water shall conform to applicable federal and state labeling laws and be labeled in compliance with the following standards:  (1) Mineral water may be labeled €œmineral water €. Bottled water to which minerals are added shall be labeled so as to disclose that minerals are added, and may not be labeled €œnatural mineral water €.  (2) Spring water may be labeled €œspring water € or €œnatural spring water €.  (3) Water containing carbon dioxide that emerges from the source and is bottled directly with its entrapped gas or from which the gas is mechanically separated and later reintroduced at a level not higher than naturally occurring in the water may bear on its label the words €œnaturally carbonated € or €œnaturally sparkling €.  (4) Bottled water which contains carbon dioxide other than that naturally occurring in the source of the product shall be labeled with the words €œcarbonated €, €œcarbonation added €, or €œsparkling € when the carbonation is obtained from a natural or manufactured source.  (5) Well water may be labeled €œwell water € or €œnatural well water €.  (6) Artesian water may be labeled €œartesian water € or €œnatural artesian water €.  (7) Purified water shall be labeled €œpurified water € and the method of preparation shall be stated on the label, except that purified water produced by distillation may be labeled as €œdistilled water €.  (8) Drinking water may be labeled €œdrinking water €.  (9) Any bottler, distributor, or vendor of bottled water whose corporate name, brand name, or trademark contains the words €œspring €, €œwell €, €œartesian €, €œmineral €, or €œnatural € or any derivative of those words shall label each bottle with the type of bottled water in typeface at least equal to the size of the typeface of the corporate name, brand name, or trademark, if the type of the bottled water is different from the type stated or implied in the corporate name, brand name, or trademark.  (10) The use of the word €œspring €, or any derivative thereof other than in a trademark, trade name, or company name to describe water that is not spring water as defined in section 328D-1 shall be prohibited.  (11) A product meeting more than one definition as stated in section 328D-1 may be identified by any of the applicable product types defined in section 328D-1, except where otherwise specifically prohibited.  (12) Supplemental printed information and graphics concerning recognized uses of the water may appear on the label but shall not imply properties of the product or preparation methods which are not factual. [L 1988, c 304, pt of §1]
HI Rev Stat § 328D-7 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-7 Exemption; soda water, soft drink.

  §328D-7 Exemption; soda water, soft drink. (a) Bottled soft drinks, soda, seltzer, or other products commonly recognized as soft drinks and labeled with a common or usual name other than one of those specified in section 328D-1 or food complying with 21 C.F.R. 165.175 are exempt from the requirements of this chapter. Water that is not in compliance with the requirements of this chapter may not be labeled as €œartesian water €, €œbottled water €, €œdistilled water €, €œdrinking water €, €œfluoridated water €, €œmineral water €, €œnatural water €, €œpurified water €, €œspring water €, or €œwell water €.  (b) Bottled water that is not sold for human consumption shall be exempt from the requirements of this chapter, provided that the product is labeled €œnot for human consumption € in prominent lettering. [L 1988, c 304, pt of §1]
HI Rev Stat § 328D-8 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-8 Rules.

  §328D-8 Rules. The director shall adopt rules pursuant to chapter 91 to implement this chapter. [L 1988, c 304, pt of §1]
HI Rev Stat § 328D-9 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-9 Administrative penalties.

  §328D-9 Administrative penalties. (a) Any person who violates this chapter or any rule adopted by the department pursuant to this chapter shall be fined not more than $10,000 for each separate offense. Any action taken to collect the penalty provided for in this subsection shall be considered a civil action.   (b) In addition to any other administrative or judicial remedy provided by this chapter, or by rules adopted pursuant to this chapter, the director may impose by order the administrative penalty specified in this section. Factors to be considered in imposing the administrative penalty include the nature and history of the violation and of any prior violation, and the opportunity, difficulty, and history of corrective action. For any judicial proceeding to recover the administrative penalty imposed, the director need only show that notice was given, a hearing was held or the time granted for requesting a hearing has expired without such a request, the administrative penalty was imposed, and that the penalty remains unpaid. [L 1988, c 304, pt of §1]
HI Rev Stat § 328D-10 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328D. Bottled Water|328D-10 Injunctive relief.

 328D-10 Injunctive relief. The director may institute a civil action in any court of competent jurisdiction for injunctive relief to prevent any violation of this chapter or any rule adopted to implement this chapter. The court shall have powers to grant relief in accordance with the Hawaii rules of civil procedure. [L 1988, c 304, pt of §1] Rules of Court  Injunctions, see HRCP rule 65.
HI Rev Stat § 328E-1 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328E. Intoxicating Compounds|328E-1 Purpose.

  §328E-1 Purpose. The purpose of this chapter is to restrict the sale and use in the State of certain compounds which induce an intoxicated condition in the user. [L 1970, c 204, §1]
HI Rev Stat § 328E-2 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328E. Intoxicating Compounds|328E-2 Use prohibited.

  §328E-2 Use prohibited. No person shall breathe, inhale or drink any compound, liquid or chemical containing toluol, hexane, trichloroethylene, acetone, toluene, ethyl acetate, methyl ethyl ketone, trichloroethane, isopropanol, methyl isobutyl ketone, methyl cellosolve acetate, cyclohexanone, or any other substance for the purpose of inducing a condition of intoxication, stupefaction, depression, giddiness, paralysis or irrational behavior, or in any manner changing, distorting or disturbing the auditory, visual or mental processes. For the purposes of this chapter, any such condition so induced shall be deemed to be an intoxicated condition. [L 1970, c 204, §2] Cross References  Use of certain chemical substances as inhalants, see §330-8.
HI Rev Stat § 328E-3 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328E. Intoxicating Compounds|328E-3 Sale or delivery to person under eighteen.

  §328E-3 Sale or delivery to person under eighteen. No person shall knowingly sell or offer for sale, deliver or give to any person under 18 years of age, unless upon written order of such person's parent or guardian, any compound liquid or chemical containing toluol, hexane, trichloroethylene, acetone, toluene, ethyl acetate, methyl ethyl ketone, trichloroethane, isopropanol, methyl isobutyl ketone, methyl cellosolve acetate, cyclohexanone, or any other substance which will induce an intoxicated condition, as defined herein, when the seller, offeror or deliveror knows or has reason to know that such compound is intended for use to induce such condition. [L 1970, c 204, §3]
HI Rev Stat § 328E-4 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|328E. Intoxicating Compounds|328E-4 When not applicable.

  §328E-4 When not applicable. This chapter shall not apply to any person who commits any act described herein pursuant to the direction or prescription of a practitioner, as defined in the €œHawaii Food, Drug and Cosmetic Act € (section 328-16). [L 1970, c 204, §4]